| Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445) |
|---|
| 10/05/2006 | US20060223729 Photodynamic inactivation of bacterial spores |
| 10/05/2006 | CA2600386A1 Indoloquinone tumor radiation sensitization |
| 10/04/2006 | EP1185309B1 Liquid gel composition for mapping a breast milk duct prior to surgical excision of the duct or other breast tissue |
| 10/04/2006 | CN1842322A Non-polar photosensitizer formulations for photodynamic therapy |
| 10/03/2006 | US7115583 Microbubble compositions and methods for oligonucleotide delivery |
| 10/03/2006 | US7115297 Shelf-stable, ready to use; to enhance delivery of active medicants/ingredients of pharmaceuticals, nutraceuticals, dietary supplements, therapeutics, diagnostics |
| 10/03/2006 | CA2415063C Photodynamic treatment and uv-b irradiation of a platelet suspension |
| 09/28/2006 | WO2006073333A3 Magnetoresonance preparations, device for individually selecting said preparations for increasing an organism life activity in actual environmental conditions |
| 09/28/2006 | DE102005013203A1 Device, useful to produce and transmit a mechanic signal comprises, two similar arrangements containing external and internal glass container filled with water arranged rotationally symmetrical and a strobe |
| 09/28/2006 | CA2602065A1 Apparatus and method for preconditioning/fixation and treatment of diseases with heat activation/release with thermo activated drugs and gene products |
| 09/27/2006 | EP1704870A1 Use of iron compounds as radiosensitizers |
| 09/26/2006 | US7112671 And texaphyrin and sapphyrin compounds, as well as other polypyrrolic macrocycles, prepared using tripyrranes as a precursor; treatment of neoplastic tissue, neovascularization |
| 09/21/2006 | WO2006097707A2 Skin composition treatment |
| 09/21/2006 | US20060212025 Method and apparatus for acne treatment |
| 09/21/2006 | US20060210553 Topical use of tyrosine kinase inhibitors of microbial origin to prevent and treat skin disorders characterised by excesssive cell proliferation |
| 09/20/2006 | EP1701745A1 Gas-filled microvesicle assembly for contrast imaging |
| 09/20/2006 | EP1701740A1 Immunologic compounds for prevention, protection, prophylaxis or treatment of immunological disorders, infections and cancer |
| 09/20/2006 | EP1701726A2 Antimicrobial photodynamic therapy compound and method of use |
| 09/20/2006 | EP1156827B1 USE OF COMPOSITIONS COMPRISING CldC AS RADIOSENSITIZERS IN THE TREATMENT OF NEOPLASTIC DISEASES |
| 09/20/2006 | EP1079875B1 Cancer treatment by ultrapheresis removing compounds of less than 120,000 daltons |
| 09/20/2006 | CN1275604C Oral compositions for white blood cell activation and proliferation |
| 09/20/2006 | CN1275603C Oral compositions for hiv-infected subjects |
| 09/19/2006 | US7109188 motexafin gadolinium or lutetium for injection in sealed glass vial purged of oxygen; radiation sensitizer acts to catalyze the oxidation of NAD(P)H, ascorbate and other reducing agents |
| 09/19/2006 | US7109031 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells |
| 09/19/2006 | US7108851 In a subject suffering from a disorder characterized by increased cell proliferation or by co-infection with mycoplasma and a second microbe; administering an agent that prevents sialic acid- mediated attachment of mycoplasma cells |
| 09/14/2006 | WO2006095870A1 Photosensitizer, protein-cleaving agent, method of cleaving protein, sugar molecule-cleaving agent, method of cleaving sugar molecule, and photodynamic therapeutic agent |
| 09/14/2006 | WO2006095708A1 Porphyrin compound and use thereof |
| 09/14/2006 | WO2006052285A3 Polymeric nanoparticles and nanogels for extraction and release of compounds |
| 09/14/2006 | US20060204442 Magnetically targetable particles comprising magnetic components and biocompatible polymers for site-specific delivery of biologically active agents |
| 09/14/2006 | US20060204437 Chlorin and bacteriochlorin-based difunctional aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals |
| 09/13/2006 | EP1699917A2 Stem cell targeting using magnetic particles |
| 09/13/2006 | EP1699470A2 Biological active blood serum obtained by electrostimulation |
| 09/13/2006 | CN1830456A Preparation method of blood induction preparation for treating AIDS |
| 09/12/2006 | US7105186 Triterpene compositions and methods for use thereof |
| 09/12/2006 | US7105151 Oxygen delivery agents and uses for the same |
| 09/12/2006 | CA2215069C Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 09/08/2006 | WO2006093969A2 Particles with high internal pressure for tissue ablation |
| 09/08/2006 | CA2598680A1 Particles |
| 09/07/2006 | US20060200213 Method and apparatus for skin treatment |
| 09/07/2006 | US20060199859 Topical medicaments and methods for photodynamic treatment of disease |
| 09/07/2006 | US20060199843 Methods for treatment and management of brain cancer using 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline |
| 09/07/2006 | US20060198901 Drugs, bio-affecting and body treating compositions |
| 09/06/2006 | EP1698350A1 Porphyrin-based compounds for tumor imaging and photodynamic therapy |
| 09/06/2006 | EP1697381A1 Mitotic kinesin inhibitors |
| 09/06/2006 | EP1696965A1 Assembly of gas-filled microvesicle with active component for contrast imaging |
| 09/06/2006 | EP1696957A2 Radiation therapy and medical imaging using uv emitting nanoparticles |
| 09/06/2006 | CN1273106C Therapeutic patch |
| 09/05/2006 | US7101571 Method and composition for hyperthermally treating cells |
| 09/05/2006 | US7101533 Agent for inducing receptor potential |
| 08/31/2006 | WO2005030118A3 Targeted release of nitric oxide in the cns circulation for modulating the bbb and treating disorders |
| 08/31/2006 | US20060194754 Detecting nucleotide sequence using gene expression of reporter molecule |
| 08/31/2006 | US20060193835 Treatment of congestive heart failure |
| 08/30/2006 | EP1695737A1 Apparatus for transmission of energetic vibration information |
| 08/30/2006 | EP1694322A2 Use of beta-lapachone for protecting against radiation injury |
| 08/30/2006 | EP1429758A4 Photodynamic porphyrin antimicrobial agents |
| 08/30/2006 | CN1824309A Method of preparing soluble vitamin for injection using ultra sonic wave oscillation technology and its medicinal preparation |
| 08/29/2006 | US7098238 2-pyrrolidone derivatives that are photolabile degradation products of bilirubin or biliverdin; used to detect vasospasm or vasoconstriction |
| 08/29/2006 | US7098187 for inhibiting endothelial cell proliferation or endothelial tube formation in in vitro or in vivo bioassay |
| 08/29/2006 | US7097826 Conjugates of ditetratriethylamine pentacarboxylic acid (DTPA) and bisaminoethanethiol (N2S2); for magnetic resonance (MR) imaging; for tumor visualization and necrosis |
| 08/24/2006 | WO2006089251A2 SYNERGISTIC EFFECT OF TGF-β BLOCKADE AND IMMUNOGENIC AGENTS ON TUMORS |
| 08/24/2006 | WO2006089007A2 Cyclodextrin-based polymers containing photocleavable linkers for drug delivery |
| 08/24/2006 | WO2006088476A2 Carboranylporphyrins and uses thereof |
| 08/24/2006 | US20060188525 Relieving spastic muscle pain; ultrasonic frequency disruption of stratum corneum and applying patch containing neurotoxin |
| 08/24/2006 | CA2598090A1 Synergistic effect of tgf-beta blockade and immunogenic agents on tumors |
| 08/24/2006 | CA2567468A1 Carboranylporphyrins and uses thereof |
| 08/23/2006 | EP1692507A1 Water-soluble compound |
| 08/23/2006 | EP1691838A2 Radiosensitizer conjugate to improve the efficacy of radiolabeled drugs |
| 08/23/2006 | EP1037673B1 Charged lipids and uses for the same |
| 08/23/2006 | CN1823038A Amphiphilic trisulfonated porphyrazines for photodynamic applications in medicine |
| 08/23/2006 | CN1822807A Regulation of matrix metalloproteinase gene expression using specific and selective electrical and electromagnetic signals |
| 08/22/2006 | US7094786 Method of treating nausea, vomiting, retching or any combination thereof |
| 08/17/2006 | WO2006085517A1 Ointment preparation or suppository for pdt based on chlorin or porphyrin derivative |
| 08/17/2006 | WO2005089813A3 Receptor-avid exogenous optical contrast and therapeutic agents |
| 08/17/2006 | US20060184074 Solid hydrogel coupling for ultrasound imaging and therapy |
| 08/17/2006 | US20060183704 Method to inhibit cell growth using oligonucleotides |
| 08/16/2006 | EP1689441A1 Bonding tissues and cross-linking proteins with naphthalimide compounds |
| 08/16/2006 | EP1404678B1 Water-soluble porphyrin derivatives for photodynamic therapy, their use and manufacture |
| 08/16/2006 | CN1819831A Cancer combination therapy comprising AZD217 and ZD1839 |
| 08/16/2006 | CN1819818A Process for the preparation of micron-size crystalline particles using a solvent, a non-solvent and ultrasonic energy |
| 08/15/2006 | US7090691 Photodynamic therapy for the treatment of hair loss |
| 08/15/2006 | CA2270558C Treatment of autoimmune diseases by photochemotherapy |
| 08/10/2006 | US20060178736 Stent for neutron capture therapy and method of manufacture therefor |
| 08/10/2006 | US20060178314 Methods and compositions for treating atheroma, tumors and other neoplastic tissues |
| 08/10/2006 | US20060177457 Are designed to produce both Type 1 and Type 2 phototherapeutic effect at once using dual wavelength light source that will produce singlet oxygen and free radicals at the lesion of interest; for dual phototherapy of tumors and other lesions |
| 08/10/2006 | US20060177374 Treatment of cancer with active vitamin D compounds in combination with radiotherapeutic agents and treatments |
| 08/09/2006 | EP1686981A1 Combinational radiotherapy and chemotherapy compositions and methods |
| 08/09/2006 | EP1446124B1 Combination therapy comprising zd6474 and a taxane |
| 08/09/2006 | EP1372741B1 Morpholino imaging and therapy |
| 08/09/2006 | EP1265546A4 Methods and apparatus for optical imaging |
| 08/09/2006 | EP1181026B1 Improved method for treating mammals with modified mammalian blood |
| 08/09/2006 | EP1133319B1 Photosensitizer conjugates for targeting intracellular pathogens |
| 08/08/2006 | US7087214 Water-soluble porphyrin platinum compounds of the tetraarylporphyrin platinum derivatives type or of the hematoporphyrin platinum derivatives type with high tumor selectivity and their use for the treatment of benign and |
| 08/03/2006 | WO2006080424A1 Low allergen milk obtained using electrical energy |
| 08/03/2006 | WO2006080243A1 Coated magnetic particle containing preparation, process for producing the same and diagnostic therapeutic system |
| 08/03/2006 | WO2006056227A8 Conjugates comprising the active agent and flanking or branched-chain peptides |
| 08/03/2006 | US20060171893 Antineoplastic agents targeted via glut transporters |
| 08/02/2006 | EP1686096A2 Antioxidants in clusters of structured water |
| 08/02/2006 | EP1684724A2 Enhanced drug delivery |
| 08/02/2006 | EP1455828B1 Photosensitizer functionalised nanoparticles |
| 08/02/2006 | EP1017397B1 Photosensitizer conjugates for pathogen targeting |